Gadoteridol( SQ-32692 | Gd-HP-DO3A | ProHance )

Catalog No. M27077 CAS No. 120066-54-8

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Group Booking Get Quotation Bulk Inquiry Add to Cart

Product Name

Gadoteridol
Note

Research use only, not for human use.
Brief Description

Gadoteridolused in the imaging of the central nervous system that is used for a gadolinium-based MRI contrast agent.
Description

Gadoteridolused in the imaging of the central nervous system that is used for a gadolinium-based MRI contrast agent.
In Vitro

——
In Vivo

Gadoteridol (1 mM; intracerebral injection; once) enhances distribution of rAAV1 in the rat hippocampus. Animal Model:Sprague-Dawley rats (3 -5 months) Dosage:1 mM/rat Administration:Intracerebral injection, once, co-infused with rAAV1 or AAV5Result:Increased the transduction efficiency of AAV1 but not AAV5.
Synonyms

SQ-32692 | Gd-HP-DO3A | ProHance
Pathway

Others
Target

Other Targets
Recptor

——
Research Area

——
Indication

——

CAS Number

120066-54-8
Formula Weight

557.68
Molecular Formula

C17H28GdN4O7
Purity

>98% (HPLC)
Solubility

In Vitro:?H2O : ≥ 280 mg/mL (502.08 mM))
SMILES

[Gd+3]1234567[N]8(CC[N]1(CC[N]2(CC[N]3(CC8)CC([O-]4)=O)CC([O-]5)=O)CC([O-]6)=O)CC(C)O7
Chemical Name

——

1.Cuendet M, et al. Antitumor activity of bruceantin: an old drug with new promise. J Nat Prod. 2004 Feb;67(2):269-72.

Calculator

molnova catalog